MintNeuro Strengthens Neurotech Semiconductor Platform and Industry Profile

MintNeuro, a London-based deep-tech start-up developing implantable neurotechnology, featured in several updates this week as it advanced its semiconductor platform and industry visibility. The company positions its semiconductor layer as critical infrastructure for scalable brain-computer interfaces and closed-loop neurotechnology systems.

CEO and co-founder Dorian Haci, PhD, is presenting MintNeuro’s platform at the Start-Up Showcase during WIRED Health London 2026 on April 16 at Outernet London. The ten-minute session will introduce the company’s advanced semiconductor solutions for next-generation neurotechnology and minimally invasive neural implants focused on brain health.

Participation in WIRED Health, a curated event attracting disruptors, scientists, and health-technology leaders, is aimed at raising MintNeuro’s profile with potential partners, customers, and investors. The showcase, judged by media and industry figures, may help validate MintNeuro’s technology roadmap and support future collaboration opportunities.

Beyond conference exposure, MintNeuro is expanding its engineering team in London, recruiting senior analogue and mixed-signal IC designers, software and firmware engineers, junior electronics roles, and interns. This hiring push signals a transition from early research to more advanced product development in ultra-low-power, high-performance silicon for implantable medical devices.

Haci emphasized in a discussion with Cloudberry VC that MintNeuro favors heterogeneous integration, chiplets, and modular, standardized chip platforms over bespoke hardware. This strategy is intended to cut development costs and time-to-market while enabling applications in stroke recovery, epilepsy, Parkinson’s disease, dementia, and severe mental health disorders.

Thought leadership also supported the company’s visibility, with Haci outlining MintNeuro’s vision for neuro-aware systems in Test Labs – Medical Devices’ Outlook magazine. He is additionally slated to speak at Hardware Pioneers Max 2026 in London on the integration of neuroscience, semiconductor technology, and next-generation hardware for brain-computer interfaces.

While no new funding rounds, revenue data, or commercialization timelines were disclosed, the latest developments highlight MintNeuro’s focus on platform-building and ecosystem positioning. Overall, the week reflected steady progress in technical capability, talent expansion, and brand recognition for the neurotechnology start-up.